Indication

Reflux esophagitis

Reflux esophagitis is an inflammatory disorder of the gastrointestinal system characterized by mucosal injury and inflammation of the distal esophagus. Read more about Reflux esophagitis

132 drugs 108 manufacturers

Advertisement

Drugs that treat it

Common Reflux esophagitis therapies.

Showing 73–81 of 132 drugs

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
RUGBY
Filter & compare in the drug finder →Opens the drug finder with Reflux esophagitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Reflux esophagitis.

Reflux esophagitis is an inflammatory disorder of the gastrointestinal system characterized by mucosal injury and inflammation of the distal esophagus.

It represents an objective, erosive manifestation of gastroesophageal reflux disease, primarily occurring in adults when gastric acid, pepsin, and bile persistently backflow past an incompetent lower esophageal sphincter.

Pathophysiologically, this chemical exposure disrupts the epithelial barrier, triggering a cytokine-mediated inflammatory response that leads to visible mucosal breaks, erosions, or ulcerations.

Clinically, affected patients commonly present with persistent heartburn, acid regurgitation, chest pain, and dysphagia, and prolonged inflammation may progress to complications such as peptic strictures or Barrett's esophagus.

Personalize your experience

Follow Reflux esophagitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it